中国药企热衷对美出口仿制药
<p><span word="Chinese">Chinese</span> <span word="pharmaceutical">pharmaceutical</span> <span word="companies">companies</span> <span word="are">are</span> <span word="stepping">stepping</span> <span word="up">up</span> <span word="their">their</span> <span word="push">push</span> <span word="into">into</span> <span word="the">the</span> <span word="US">US</span> <span word="generic">generic</span> <span word="drugs">drugs</span> <span word="market">market</span> <span word="with">with</span> <span word="the">the</span> <span word="number">number</span> <span word="of">of</span> <span word="approvals">approvals</span> <span word="for">for</span> <span word="copycat">copycat</span> <span word="medicines">medicines</span> <span word="almost">almost</span> <span word="doubling">doubling</span> <span word="last">last</span> <span word="year">year</span>.</p><p>中国制药公司正加大力度打入美国仿制药市场，去年中国药企获批的仿制药品种增加近一倍。</p><p><span word="In">In</span> 2017, <span word="Chinese">Chinese</span> <span word="drugmakers">drugmakers</span> <span word="won">won</span> <span word="US">US</span> <span word="Food">Food</span> <span word="and">and</span> <span word="Drug">Drug</span> <span word="Administration">Administration</span> <span word="approval">approval</span> <span word="for">for</span> 38 <span word="generic">generic</span> <span word="drugs">drugs</span>, <span word="cheaper">cheaper</span> <span word="versions">versions</span> <span word="of">of</span> <span word="treatments">treatments</span> <span word="for">for</span> <span word="which">which</span> <span word="patents">patents</span> <span word="have">have</span> <span word="expired">expired</span>, <span word="up">up</span> <span word="from">from</span> 22 <span word="a">a</span> <span word="year">year</span> <span word="earlier">earlier</span>. <span word="This">This</span> <span word="month">month</span>, <span word="Jiangsu">Jiangsu</span> <span word="Hengrui">Hengrui</span> <span word="Medicine">Medicine</span>, <span word="China">China</span>’<span word="s">s</span> <span word="largest">largest</span> <span word="pharmaceutical">pharmaceutical</span> <span word="company">company</span> <span word="with">with</span> <span word="a">a</span> $35<span word="bn">bn</span> <span word="market">market</span> <span word="capitalisation">capitalisation</span>, <span word="became">became</span> <span word="the">the</span> <span word="latest">latest</span> <span word="to">to</span> <span word="win">win</span> <span word="approval">approval</span> <span word="for">for</span> <span word="its">its</span> <span word="generic">generic</span> <span word="of">of</span> <span word="anaesthetic">anaesthetic</span> <span word="desflurane">desflurane</span>.</p><p>2017年，中国药企共有38款仿制药（专利已过期、其他药企可以仿制的较低价药品）获得了美国食品药品管理局(<span word="FDA">FDA</span>)的批准，而上一年这个数字为22款。本月，市值350亿美元的中国最大药企江苏恒瑞医药(<span word="Jiangsu">Jiangsu</span> <span word="Hengrui">Hengrui</span> <span word="Medicine">Medicine</span>)凭借其仿制麻醉剂地氟烷(<span word="desflurane">desflurane</span>)，成为最新一家获<span word="FDA">FDA</span>认证的中国药企。</p>
页:
[1]